Jim Simons's position in Dyne Therapeutics is currently worth $6.69M. That's 0.01% of their equity portfolio (1219th largest holding). The first Dyne Therapeutics trade was made in Q3 2021. Since then Jim Simons bought shares seven more times and sold shares on six occasions. The stake costed the investor $5.01M, netting the investor a gain of 34% so far.